TIM-3 Expression on Dendritic Cells in Colorectal Cancer

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• T-cell immunoglobulin and mucin-domain containing-3 (TIM-3) is a known regulator of T cells and is expressed on dendritic cells (DCs).
• Inhibiting TIM-3 on DCs may enhance T cell-mediated anti-tumor immunity.
• Understanding TIM-3 expression on DCs within the tumor microenvironment (TME) is crucial for colorectal cancer (CRC) research.

Purpose of the Study:

• To investigate the expression of TIM-3 on DCs within the TME of colorectal cancer (CRC).
• To analyze the association between TIM-3 expression and DC infiltration in CRC.
• To compare TIM-3 expression levels on immature versus mature DCs and its relation to STING expression.

Main Methods:

• Analysis of transcriptomic data from a public database (n=592) and immunohistochemical evaluation of CRC patient cohorts (n=115).
• Flow cytometry to examine TIM-3 expression on DCs in vitro.
• Western blotting to assess the expression of TIM-3, cGAS, and STING on immature and mature DCs.

Main Results:

• TIM-3 (HAVCR2) expression strongly correlated with DC infiltration in the CRC TME.
• Immunohistochemistry confirmed TIM-3 expression on tumor-infiltrating DCs, with decreased numbers at the invasive front in advanced stages.
• TIM-3 expression was higher on immature DCs compared to mature DCs, inversely related to STING expression.

Conclusions:

• TIM-3 is significantly expressed on tumor-infiltrating DCs in colorectal cancer.
• TIM-3 expression is higher on immature DCs than mature DCs.
• The inverse relationship between TIM-3 and STING expression on DCs warrants further investigation in the context of CRC immunity.